Table 3.

Agents approved 2021–2022.

Name/year	Mechanism	N & C codes	Structure #
Imeglimin/2021	GSIS enhancement	S*/NM	Fig. 13.87
Zegalogue/2021	Glucagon receptor agonist	ND	Fig. 13.88
Tirzepatide/2022	GIP/GLP-1 agonist	ND	Fig. 13.89